About Zinc finger MYND domain-containing protein 10
Zinc finger MYND domain-containing protein 10 (ZMYND10) is a protein
from Homo sapiens identified by UniProt accession
O75800, 440 residues long.
MolForge cross-references it against 0 known binders and
71 disease associations.
Target properties
| Protein name | Zinc finger MYND domain-containing protein 10 |
| UniProt accession | O75800 |
| Gene | ZMYND10 |
| Organism | Homo sapiens |
| Length | 440 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (71)
Diseases linked to this target (Open Targets).
- primary ciliary dyskinesia · score 0.70
- genetic disorder · score 0.19
- neoplasm · score 0.08
- mean platelet volume · score 0.08
- mathematical ability · score 0.07
- schizophrenia · score 0.06
- blood protein measurement · score 0.05
- wellbeing measurement · score 0.05
- body height · score 0.04
- neuroticism measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75800-F1 | alphafold | PREDICTED | 88.74 | — |
Amino-acid sequence (440 residues)
MGDLELLLPG EAEVLVRGLR SFPLREMGSE GWNQQHENLE KLNMQAILDA TVSQGEPIQE LLVTHGKVPT LVEELIAVEM WKQKVFPVFC RVEDFKPQNT FPIYMVVHHE ASIINLLETV FFHKEVCESA EDTVLDLVDY CHRKLTLLVA QSGCGGPPEG EGSQDSNPMQ ELQKQAELME FEIALKALSV LRYITDCVDS LSLSTLSRML STHNLPCLLV ELLEHSPWSR REGGKLQQFE GSRWHTVAPS EQQKLSKLDG QVWIALYNLL LSPEAQARYC LTSFAKGRLL KLRAFLTDTL LDQLPNLAHL QSFLAHLTLT ETQPPKKDLV LEQIPEIWER LERENRGKWQ AIAKHQLQHV FSPSEQDLRL QARRWAETYR LDVLEAVAPE RPRCAYCSAE ASKRCSRCQN EWYCCRECQV KHWEKHGKTC VLAAQGDRAK
Explore Zinc finger MYND domain-containing protein 10 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets